( Health Times, reporter Xu Tingting, intern reporter Tan Qixin) Health Times reporters combed through reports from the Korean Disease Management Agency and reports from authoritative media such as Yonhap News Agency, Joongang Ilbo, Kookmin Ilbo, and so on. As of November 3, the number of deaths after vaccination with flu and It rose to 83 people. The
incident originated on September 22. The South Korean government announced that from now on, children from 6 months to 18 years old, pregnant women and elderly people over 62 years old in South Korea can receive the flu vaccine for free, covering 19 million people. . Soon afterwards, cases of death after flu vaccination occurred in various parts of South Korea, most of them were people over 70 years old. Died between 4 and 85 hours after vaccination. The profile picture of
has nothing to do with this article. Zhang Tao/photographed by
from 1 to 83
The first death after influenza vaccination occurred on October 16. In the morning, a 17-year-old teenager in Incheon died suddenly after receiving influenza vaccination. According to Yonhap News Agency, this person was vaccinated for free at noon on the 14th. There was no abnormal reaction before and after the vaccination, but died on the morning of the 16th two days later. The cause is unknown. The
case did not cause public anxiety and official response. However, subsequent reports of deaths after influenza vaccination continued to increase.
On October 19, in Daegu, a 70-year-old man died 5 hours after being vaccinated.
On October 20, in Datian City, an 82-year-old man fell into a coma after being vaccinated and died after being sent to the hospital.
On the same day, in Jeollabuk-do, a 78-year-old woman died suddenly one day after vaccination.
On the morning of October 21, Jeju Island, a 69-year-old man died the next day after being vaccinated.
On the afternoon of October 21, a citizen of Seoul and a citizen of Goyang died after being vaccinated.
......
However, this free influenza vaccination program has not ended.
On October 21, the Korean Disease Management Agency held an emergency press conference and stated that it is not clear whether there is a direct causal relationship between the death cases and vaccination, and it is too early to stop vaccination.
On the evening of October 23, the Korean Agency for Disease Control stated that the direct link between influenza vaccination and deaths is not yet clear, and vaccination will continue. "Z5z
On October 26, the Director of the Korean Agency for Disease Control, Jeong Eun Kyung, said again at a press conference that the investigation found that most of the deaths after influenza vaccination were elderly people, and most of them had underlying diseases. Therefore, the government believes that there is no need to stop vaccination.
At the same time, the number of deaths after influenza vaccination continues to rise. The latest data from the Korean Agency for Disease Control shows that the number of deaths after influenza vaccination in South Korea has risen to 83. Among the deaths, 71 people were over 70 years old, accounting for 85.5. %. Judging from the time from flu vaccination to death, 50 people died within 48 hours of flu vaccination and 13 people died less than 24 hours after vaccination. The Korean Agency for Disease Control reiterated, After investigating the cause of death of 72 of them, it was found that the correlation between the cause of death and vaccination was very low, so it was decided to continue the influenza vaccination plan.
In some areas, the vaccine involved in the case was discontinued. The death of the vaccine has raised questions about the safety of influenza vaccines in South Korea. The Korean Medical Association called on: "Government departments should urgently stop the vaccination plan and ensure that the vaccine is safe to alleviate public anxiety. "Z5z
In addition, the flu vaccine incident is also affecting local people's concerns about the safety of the new crown vaccine that will be launched. In early October, a survey of 2500 people conducted in Gyeonggi Province, South Korea's most populous province, showed that 62% Respondents said that they will never get the vaccine until the new crown vaccine is proven to be completely safe. The
reporter inquired about the information on the official website of the Korean Agency for Disease Control and found that the influenza vaccine used in the Korean free vaccination plan was supplied by five pharmaceutical companies, namely Local GC Pharmaceutical Company, SK Biotech, Korea Vaccine Company, Boryeong Pharmaceutical Company, and France’s Sanofi Pasteur. In addition, GlaxoSmithKline is not involved in the plan, but is also a producer of paid influenza vaccines in Korea One.
Late at night on October 25, Singapore’s health department issued a statement saying that in view of South Korea’s reports of multiple influenza vaccinationDeaths after vaccination. Although Singapore has not reported deaths after vaccination, for precaution, Singapore has suspended the use of two influenza vaccines adopted in South Korea, namely SKY Cellflu Quadrivalent (produced by SK Biotechnology) and Vaxigrip Tetra (France competition). Produced by Nofi Pasteur). The
Health Times reporter found that on September 22, the day before the free flu vaccination program in South Korea is about to start, the vaccine program for teenagers under the age of 18 and pregnant women was urgently suspended, and it was not resumed until October 13. , The reason is that part of the vaccines mainly supplied to teenagers are not stored in cold storage as required during the transportation. The Korean Food and Drug Safety Agency immediately announced the recall of this batch of vaccines. Subsequently, the Korean Food and Drug Safety Agency responded that about 2,300 people had been injected with this batch of vaccines. However, the vaccine will only be invalid if the vaccine is not refrigerated and will not produce toxic and harmful substances.
On October 6, the influenza vaccine Kovax Influ 4ga PF Injection (PFS) produced by Korea Vaccine was found to “contain white particles, scattered in 4 production lines, totaling 61,500 doses.” Korea Food and Medicine The Product Safety Department urgently ordered the recall of the problem vaccine on October 9 and launched an investigation.
On October 27, the Korean Food and Drug Safety Agency issued another investigation result on the appearance of white particles in the influenza vaccine, saying that the particles were protein, and there was no problem with the safety and effectiveness of the related vaccine. But in order to dispel public concerns about vaccine safety, all problematic vaccines will be scrapped.
is not on the market in my country.
Health Times reporters inquired from the National Food and Drug Administration and found that none of the influenza vaccines involved in South Korea are currently on the market in my country. A reporter from
inquired about data from the my country Institute for Food and Drug Control and found that the influenza vaccines that have been approved for marketing in mainland China include trivalent inactivated influenza vaccine (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), which will be issued in 2020-2021 There are four vaccine manufacturers including Hualan Biology, Changchun Biology, Shenzhen Sanofi Pasteur, and Beijing Kexing. As of October 20, the number of influenza vaccines issued this year for the 2019-2020 influenza season has reached 20,836,500. However, there have been no reports of related adverse events.
The vaccine of Sanofi company involved in the Korean vaccine incident is Vaxigrip Tetra, which is a quadrivalent inactivated vaccine that has not been used in the mainland of my country, but the trivalent inactivated vaccine is supplied in my country. Qiao Youlin, director of the Tumor Epidemiology Research Office of the Cancer Hospital of the Chinese Academy of Medical Sciences and professor at the School of Medicine and Public Health of the Peking Union Medical College, told the Health Times reporter that to ensure the effectiveness and safety of mass vaccination of vaccines, it is only the first to be approved for listing. As a biological product, the related cold chain and transportation and storage of vaccines are very critical. For example, influenza vaccines need to be refrigerated in an environment of 2 to 8 degrees Celsius. Therefore, it is necessary for regions/countries to establish a complete vaccine biologics circulation system. .
Pediatrician Li Peng of Beijing Chaoyang Hospital said in an interview with the Health Times that in addition to being self-limiting, influenza has the possibility of causing serious adverse complications and death. Vaccination is the best way to prevent influenza, and the vaccination should be timely. Vaccination. "From the perspective of the total number of people vaccinated, the probability of death after this vaccination in South Korea is still very low. Moreover, my country's influenza vaccine research and development and production technology are already mature, and the safety of influenza vaccine is relatively high, so there is no need If you are too entangled with the side effects of the flu vaccine, you can rest assured to get the vaccine."
